Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle is a journal indexed in SJR in Physiology (medical) and Orthopedics and Sports Medicine with an H index of 112. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2250 €. The scope of the journal is focused on cachexia, sarcopenia, muscle, muscle wasting, wasting syndromes, body composition. It has an SJR impact factor of 3,416 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,416.
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
3,416
H-index
112
Docs (year)
254
Docs 3y
694
Total refs
10047
Cites 3y
7129
Citable 3y
633
Cites/Doc 2y
9.89
Ref/Doc
39.56
Immediate OA
2250 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients
View moreTumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer
View moreErratum to: Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility
View moreEndocrine determinants of incident sarcopenia in middle-aged and elderly European men
View moreDysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue
View moreDiabetic mice exhibited a peculiar alteration in body composition with exaggerated ectopic fat deposition after muscle injury due to anomalous cell differentiation
View moreDiabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
View moreDegenerin channel activation causes caspase-mediated protein degradation and mitochondrial dysfunction in adultC.elegansmuscle
View moreConcurrent evolution of cancer cachexia and heart failure: bilateral effects exist
View moreComputed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?
View moreCaveolin-3 deficiency associated with the dystrophy P104L mutation impairs skeletal muscle mitochondrial form and function
View moreCancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer
View moreCancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
View more1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model
View moreCachexia in heart disease: highlights from the ESC 2010
View moreBreakthrough in cachexia treatment through a novel selective androgen receptor modulator?!
View moreAttenuation of muscle wasting in murine C2C12myotubes by epigallocatechin-3-gallate
View moreAssociation between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy
View moreAssessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility
View moreAldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients
View moreAge- and gender-dependent values of skeletal muscle mass in healthy children and adolescents
View moreAdipose depot gene expression and intelectin-1 in the metabolic response to cancer and cachexia
View moreAdipoRon
View moreA systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project
View more